Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin
- 1 June 2014
- journal article
- review article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 39, 161-167
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Fabrication and characterization of monodisperse PLGA–alginate core–shell microspheres with monodisperse size and homogeneous shells for controlled drug releaseActa Biomaterialia, 2013
- On designing particulate carriers for encapsulation and controlled release applicationsPowder Technology, 2013
- Osmotic capsules: A universal oral, controlled-release drug delivery dosage formJournal of Controlled Release, 2011
- Encapsulation and release of rifampicin using poly(vinyl pyrrolidone)-poly(methacrylic acid) polyelectrolyte capsulesMaterials Science and Engineering: C, 2009
- Development and characterization of wheat gluten microspheres for use in a controlled release systemMaterials Science and Engineering: C, 2009
- Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticlesColloids and Surfaces B: Biointerfaces, 2008
- Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2007
- Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophagesInternational Journal of Pharmaceutics, 2004
- Respirable PLGA Microspheres Containing Rifampicin for the Treatment of Tuberculosis: Manufacture and CharacterizationPharmaceutical Research, 2000
- Solvent influence on spray-dried biodegradable microspheresJournal of Microencapsulation, 1999